160 related articles for article (PubMed ID: 33852418)
1. Transcription factor immunohistochemistry in the diagnosis of pituitary tumours.
Lenders NF; Wilkinson AC; Wong SJ; Shein TT; Harvey RJ; Inder WJ; Earls PE; McCormack AI
Eur J Endocrinol; 2021 May; 184(6):891-901. PubMed ID: 33852418
[TBL] [Abstract][Full Text] [Related]
2. Subtyping does matter in pituitary adenomas.
Kleinschmidt-DeMasters BK
Acta Neuropathol; 2006 Jan; 111(1):84-5. PubMed ID: 16328517
[No Abstract] [Full Text] [Related]
3. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
[TBL] [Abstract][Full Text] [Related]
4. Comments on the WHO histological classification of pituitary tumors.
Sano T
Acta Neuropathol; 2006 Jan; 111(1):82-3. PubMed ID: 16317556
[No Abstract] [Full Text] [Related]
5. Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours.
Lenders NF; Chui J; Low J; Inder WJ; Earls PE; McCormack AI
Pituitary; 2022 Dec; 25(6):997-1003. PubMed ID: 36271964
[TBL] [Abstract][Full Text] [Related]
6. Glycoprotein hormone alpha-subunit production and plurihormonality in human corticotroph tumours--an in vitro and immunohistochemical study.
Desai B; Burrin JM; Nott CA; Geddes JF; Lamb EJ; Aylwin SJ; Wood DF; Thakkar C; Monson JP
Eur J Endocrinol; 1995 Jul; 133(1):25-32. PubMed ID: 7542980
[TBL] [Abstract][Full Text] [Related]
7. The 2004 World Health Organization classification of pituitary tumors: is it clinically helpful?
Grossman AB
Acta Neuropathol; 2006 Jan; 111(1):76-7. PubMed ID: 16328520
[No Abstract] [Full Text] [Related]
8. A growth hormone-releasing hormone-producing pancreatic islet cell tumor metastasized to the pituitary is associated with pituitary somatotroph hyperplasia and acromegaly.
Sanno N; Teramoto A; Osamura RY; Genka S; Katakami H; Jin L; Lloyd RV; Kovacs K
J Clin Endocrinol Metab; 1997 Aug; 82(8):2731-7. PubMed ID: 9253362
[TBL] [Abstract][Full Text] [Related]
9. The WHO classification of pituitary tumours: a combined neurosurgical and neuropathological view.
Fahlbusch R; Buslei R
Acta Neuropathol; 2006 Jan; 111(1):86-7. PubMed ID: 16311771
[No Abstract] [Full Text] [Related]
10. Hormonal secretion by adult pituitary cells in culture.
Shin DH; Kim SU
Hum Pathol; 1988 Jan; 19(1):83-8. PubMed ID: 2826329
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a Novel General Pituitary Hormone Score to Evaluate the Function of the Residual Anterior Pituitary (Adenohypophysis) in Patients Following Surgery for Pituitary Adenoma.
Wang S; Ding C; Xiao D; Wu Z; Wei L
Med Sci Monit; 2018 Nov; 24():7944-7951. PubMed ID: 30397189
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas].
Brito J; Sáez L; Lemp M; Liberman C; Michelsen H; Araya AV
Rev Med Chil; 2008 Jul; 136(7):831-6. PubMed ID: 18949157
[TBL] [Abstract][Full Text] [Related]
13. Management of endocrine disease: clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies.
Raverot G; Jouanneau E; Trouillas J
Eur J Endocrinol; 2014 Apr; 170(4):R121-32. PubMed ID: 24431196
[TBL] [Abstract][Full Text] [Related]
14. Utility of GATA-3 Expression in the Analysis of Pituitary Neuroendocrine Tumour (PitNET) Transcription Factors.
Turchini J; Sioson L; Clarkson A; Sheen A; Gill AJ
Endocr Pathol; 2020 Jun; 31(2):150-155. PubMed ID: 32193825
[TBL] [Abstract][Full Text] [Related]
15. Pituitary specific transcription factor messenger ribonucleic expression in adenomatous and nontumorous human pituitary tissues.
Lloyd RV; Jin L; Chandler WF; Horvath E; Stefaneanu L; Kovacs K
Lab Invest; 1993 Nov; 69(5):570-5. PubMed ID: 8246449
[TBL] [Abstract][Full Text] [Related]
16. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
[TBL] [Abstract][Full Text] [Related]
17. Predictors of pituitary tumour behaviour: an analysis from long-term follow-up in 2 tertiary centres.
Lenders NF; Earls PE; Wilkinson AC; Costin M; Hofer M; Shein TT; Harvey RJ; Krishnan G; Picallo M; Pal A; Wass J; McCormack AI
Eur J Endocrinol; 2023 Jul; 189(1):106-114. PubMed ID: 37461224
[TBL] [Abstract][Full Text] [Related]
18. Microvessel density and area in pituitary microadenomas.
Jasek E; Furgal-Borzych A; Lis GJ; Litwin JA; Rzepecka-Wozniak E; Trela F
Endocr Pathol; 2009; 20(4):221-6. PubMed ID: 19705298
[TBL] [Abstract][Full Text] [Related]
19. Multihormonal pituitary adenomas.
Heitz PU
Horm Res; 1979; 10(1):1-13. PubMed ID: 218878
[TBL] [Abstract][Full Text] [Related]
20. A clinicopathological study of non-functioning pituitary neuroendocrine tumours using the World Health Organization 2022 classification.
Woo CS; Ho RS; Ho G; Lau HT; Fong CH; Chang JY; Leung EK; Tang LC; Ma IK; Lee AC; Lui DT; Woo YC; Chow WS; Leung GK; Tan KC; Lam KS; Lee CH
Front Endocrinol (Lausanne); 2024; 15():1368944. PubMed ID: 38756997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
